Aziz Nazha on Adverse Events Associated With Treatment for MDS

October 1, 2015
Aziz Nazha

Aziz Nazha, Hematology and Medical Oncology Fellow, Cleveland Clinic, discusses adverse events associated with treatment for myelodysplastic syndrome (MDS).

Aziz Nazha, Hematology and Medical Oncology Fellow, Cleveland Clinic, discusses adverse events associated with treatment for myelodysplastic syndrome (MDS).

Related Content:

CURE TVMDS
Areola Tattooing Helped Stephanie Wachtel Reclaim Confidence After Cancer
FDA Grants Orphan Drug Designation to MNV-201 for Myelodysplastic Syndrome
What Does Staging Mean in Liver Cancer?